scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...999490Z |
P356 | DOI | 10.1371/JOURNAL.PONE.0099490 |
P932 | PMC publication ID | 4059646 |
P698 | PubMed publication ID | 24932704 |
P5875 | ResearchGate publication ID | 263131976 |
P2093 | author name string | Ping Zhong | |
Jian Xu | |||
Ying Mao | |||
Yong Ren | |||
Zhen-Yu Zhang | |||
Yu Yao | |||
Ho-Keung Ng | |||
Liang-Fu Zhou | |||
Kay Ka-Wai Li | |||
P2860 | cites work | Medulloblastoma: experience of a single institution. | Q55477502 |
Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. | Q55481597 | ||
Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
Epidemiology of primary brain tumors: current concepts and review of the literature | Q30501715 | ||
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. | Q33539849 | ||
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept | Q33669523 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
Medulloblastoma: clinical and biologic aspects | Q34364285 | ||
Current multimodality management of medulloblastoma | Q35007079 | ||
Radiation treatment for medulloblastoma: a review of 64 cases at a single institute | Q36059176 | ||
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | Q36460209 | ||
Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults | Q36820329 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996. | Q37198737 | ||
Management of and prognosis with medulloblastoma: therapy at a crossroads | Q37322966 | ||
Medulloblastoma in children under the age of three years: a retrospective Canadian review | Q37382230 | ||
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. | Q39875833 | ||
Medulloblastoma in adults. | Q40442869 | ||
Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group | Q41162667 | ||
Current therapy and new perspectives in the treatment of medulloblastoma | Q41735764 | ||
Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma | Q43617614 | ||
Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region | Q44161027 | ||
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial | Q45120061 | ||
Influence of a child's sex on medulloblastoma outcome. | Q45986392 | ||
Do children and adults differ in survival from medulloblastoma? A study from the SEER registry | Q46866980 | ||
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse | Q48764303 | ||
Prognosis and long-term follow-up in patients with medulloblastoma | Q48820345 | ||
Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. | Q50599689 | ||
Outcome and prognostic factors of radiation therapy for medulloblastoma. | Q51054174 | ||
Survival and prognostic factors in a series of adults with medulloblastomas. | Q51872092 | ||
Medulloblastoma in adults: a series from Brazil. | Q53662864 | ||
Adult medulloblastoma: clinical profile and treatment results of 18 patients. | Q55467528 | ||
Long-term results of a prospective study on the treatment of medulloblastoma in adults. | Q55467796 | ||
Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. | Q55473265 | ||
Adult medulloblastoma: prognostic factors and patterns of relapse. | Q55475197 | ||
Medulloblastoma: time-dose relationship based on a 30-year review. | Q55477493 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | medulloblastoma | Q1333608 |
P304 | page(s) | e99490 | |
P577 | publication date | 2014-06-16 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy | |
P478 | volume | 9 |
Q33665382 | A Retrospective Study of Progression-Free and Overall Survival in Pediatric Medulloblastoma Based on Molecular Subgroup Classification: A Single-Institution Experience |
Q36383466 | IL-17 promoted the inhibition of medulloblastoma in mice by splenocyte injection |
Q50604253 | Medulloblastoma: selecting children for reduced treatment. |
Q39134342 | Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery |
Q90101021 | Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma |
Q41989047 | Risk factors for the prognosis of pediatric medulloblastoma: a retrospective analysis of 40 cases |
Q38703533 | The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis. |